lisdexamfetamine-dimesylate and Prader-Willi-Syndrome

lisdexamfetamine-dimesylate has been researched along with Prader-Willi-Syndrome* in 1 studies

1 other study(ies) available for lisdexamfetamine-dimesylate and Prader-Willi-Syndrome

Article	Year
Lisdexamphetamine as a novel therapy for hyperphagia in Prader-Willi syndrome. Journal of paediatrics and child health, 2023, Volume: 59, Issue:3 Topics: Humans; Hyperphagia; Lisdexamfetamine Dimesylate; Prader-Willi Syndrome	2023